 | Up a level |
Glintborg, Bente; Østergaard, Mikkel; Jørgensen, Jacob Brauner; Wallman, Johan K; Möller, Burkhard; Nissen, Michael J; Michelsen, Brigitte; Sexton, Joseph; Ørnbjerg, Lykke Midtbøll; Hetland, Merete Lund (2024). Biological material for biomarker research in spondyloarthritis: Mapping the availability in European rheumatology registries. (In Press). Rheumatology Oxford University Press 10.1093/rheumatology/keae369
Linde, Louise; Georgiadis, Stylianos; Ørnbjerg, Lykke M; Rasmussen, Simon H; Michelsen, Brigitte; Askling, Johan; Di Giuseppe, Daniela; Wallman, Johan K; Závada, Jakub; Pavelka, Karel; Bernardes, Miguel; Matos, Carolina O; Glintborg, Bente; Loft, Anne Gitte; Nordström, Dan; Kuusalo, Laura; Möller, Burkhard; Nissen, Michael J; Codreanu, Catalin; Mogosan, Corina; ... (2024). Comparing DAPSA, DAPSA28 and DAS28-CRP in patients with psoriatic arthritis initiating a first TNF-inhibitor across nine European countries. (In Press). Arthritis care & research Wiley 10.1002/acr.25396
Hellamand, Pasoon; van de Sande, Marleen G H; Ørnbjerg, Lykke M; Klausch, Thomas; Eklund, Kari K; Relas, Heikki; Santos, Maria J; Vieira-Sousa, Elsa; Loft, Anne G; Glintborg, Bente; Østergaard, Mikkel; Lindström, Ulf; Wallman, Johan K; Michelsen, Brigitte; Fagerli, Karen M; Castrejón, Isabel; Gudbjornsson, Bjorn; Love, Thorvardur J; Vencovský, Jiří; Nekvindová, Lucie; ... (2024). Sex differences in the effectiveness of first-line tumor necrosis factor inhibitors in psoriatic arthritis; results from the EuroSpA Research Collaboration Network. Arthritis & rheumatology, 76(4), pp. 587-598. Wiley-Blackwell 10.1002/art.42758
Linde, Louise; Ørnbjerg, Lykke M; Georgiadis, Stylianos; Rasmussen, Simon H; Lindström, Ulf; Askling, Johan; Michelsen, Brigitte; Di Giuseppe, Daniela; Wallman, Johan K; Gudbjornsson, Bjorn; Love, Thorvardur Jon; Nordström, Dan C; Yli-Kerttula, Timo; Nekvindová, Lucie; Vencovský, Jiří; Iannone, Florenzo; Cauli, Alberto; Loft, Anne Gitte; Glintborg, Bente; Laas, Karin; ... (2024). Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF-inhibitor: results from 13 European registries. Rheumatology, 63(3), pp. 751-764. Oxford University Press 10.1093/rheumatology/kead284
